As of May 2026, generic semaglutide retails locally in Canada for roughly $88 to $100 CAD per month at major pharmacies, according to CBC News reporting
Glucose-dependent insulinotropic polypeptide receptor agonism for treating metabolic conditions was initially dismissed due to concerns that GIP receptor agonists (GIP RA) fail to stimulate insulin secretion in patients with type 2 diabetes, stimulate glucagon secretion worsening hyperglycaemia, and contribute to obesity [57]
Our staff will review the list along with the reason for treatment and determine your eligibility
Despite extensive research highlighting their neuroprotective, antioxidant, anti-inflammatory, antibacterial, dermatological, antitumor, and antidiabetic properties, the underlying mechanisms remain only partially understood